X4 Pharmaceuticals logo

X4 Pharmaceuticals Share Price Today

(NASDAQ: XFOR)

X4 Pharmaceuticals share price is $0.37 & ₹32.18 as on 6 Mar 2025, 2.30 'hrs' IST

$0.37

Market is closed - opens 8 PM, 06 Mar 2025

View live X4 Pharmaceuticals share price in Dollar and Rupees. Guide to invest in X4 Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in X4 Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

X4 Pharmaceuticals share price movements

  • Today's Low: $0.35
    Today's High: $0.38

    Day's Volatility :6.33%

  • 52 Weeks Low: $0.26
    52 Weeks High: $1.60

    52 Weeks Volatility :83.68%

X4 Pharmaceuticals (XFOR) Returns

PeriodX4 Pharmaceuticals IncIndex (Russel 2000)
3 Months
-5.96%
0.0%
6 Months
-45.82%
0.0%
1 Year
-62.03%
0.0%
3 Years
-82.99%
-11.6%

X4 Pharmaceuticals (XFOR) Key Statistics

in dollars & INR

Previous Close
$0.3658
Open
$0.37
Today's High
$0.3759
Today's Low
$0.3521
Market Capitalization
$61.4M
Today's Volume
$177.8K
52 Week High
$1.6
52 Week Low
$0.2612
Revenue TTM
$1.1M
EBITDA
$-130.3M
Earnings Per Share (EPS)
$-0.08
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-26.35%

How to invest in X4 Pharmaceuticals Stock (XFOR) from India?

It is very easy for Indian residents to invest directly in X4 Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the X4 Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for X4 Pharmaceuticals or XFOR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of X4 Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of X4 Pharmaceuticals shares which would translate to 2.351 fractional shares of X4 Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like X4 Pharmaceuticals, in just a few clicks!

Returns in X4 Pharmaceuticals (XFOR) for Indian investors in Rupees

The X4 Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

X4 Pharmaceuticals investment value today

Current value as on today

₹43,504

Returns

₹56,496

(-56.5%)

Returns from X4 Pharmaceuticals Stock

₹61,458 (-61.46%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards X4 Pharmaceuticals (XFOR)

-52%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for X4 Pharmaceuticals Stock from India on INDmoney has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in X4 Pharmaceuticals

  • Bain Capital Life Sciences Investors, LLC

    9.92%

  • NEA Management Company, LLC

    8.79%

  • BlackRock Inc

    6.49%

  • Vanguard Group Inc

    4.81%

  • Orbimed Advisors, LLC

    4.18%

  • Kingdon Capital Management LLC

    2.89%

Analyst Recommendation on X4 Pharmaceuticals

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for X4 Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on X4 Pharmaceuticals Stock (XFOR)

What analysts predicted

Upside of 744.59%

Target:

$3.13

Current:

$0.37

Insights on X4 Pharmaceuticals Stock (Ticker Symbol: XFOR)

  • Price Movement

    In the last 1 month, XFOR stock has moved down by -40.7%
  • XFOR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 124.0%
  • XFOR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 129.4%
  • Price to Sales

    ForXFOR every $1 of sales, investors are willing to pay $61.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

X4 Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

X4 Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

X4 Pharmaceuticals (XFOR) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
X4 Pharmaceuticals Inc logo
-39.04%
-45.82%
-62.03%
-82.99%
-95.98%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
X4 Pharmaceuticals Inc logo
2.85
NA
NA
-0.15
-0.26
-0.47
NA
0.35
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
X4 Pharmaceuticals Inc logo
Buy
$61.4M
-95.98%
2.85
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About X4 Pharmaceuticals

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase II clinical trial to treat congenital, idiopathic, or cyclic neutropenia. The company is also developing X4P-003, a CXCR4 antagonist for the treatment of CXCR4 dependent disorders and primary immunodeficiencies; and X4P-002, a CXCR4 antagonist for the treatment of blood-brain barrier diseases. It has a license agreement with Abbisko Therapeutics Co Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company is headquartered in Boston, Massachusetts.
Organization
X4 Pharmaceuticals
Employees
143
CEO
Dr. Paula Ragan Ph.D.
Industry
Biotechnology

Management People of X4 Pharmaceuticals

NameTitle
Dr. Paula Ragan Ph.D.
CEO, President & Director
Mr. Adam S. Mostafa
CFO, Treasurer & Corporate Secretary
Dr. Christophe Arbet-Engels M.B.A., M.D., Ph.D.
Chief Medical Officer
Dr. Richard Peters M.D., Ph.D.
Chairman of the Board & Founder
Dr. Renato T. Skerlj Ph.D.
Founder
Dr. Keith T. Flaherty M.D.
Founder & Member of Corporate Advisory Board
Dr. Mary DiBiase Ph.D.
Chief Operating Officer
Dr. Arthur Taveras Ph.D.
Chief Scientific Officer
Dr. Robert David Arbeit
Senior Vice President of Clinical Development and Translational Research
Mr. Mark Baldry M.B.A.
Chief Commercial Officer

Important FAQs about investing in XFOR Stock from India :

What is X4 Pharmaceuticals share price today?

X4 Pharmaceuticals share price today stands at $0.37, Open: $0.37 ; Previous Close: $0.37 ; High: $0.38 ; Low: $0.35 ; 52 Week High: $1.60 ; 52 Week Low: $0.26.

The stock opens at $0.37, after a previous close of $0.37. The stock reached a daily high of $0.38 and a low of $0.35, with a 52-week high of $1.60 and a 52-week low of $0.26.

Can Indians buy X4 Pharmaceuticals shares?

Yes, Indians can invest in the X4 Pharmaceuticals (XFOR) from India.

With INDmoney, you can buy X4 Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy X4 Pharmaceuticals at zero transaction cost.

How can I buy X4 Pharmaceuticals shares from India?

It is very easy to buy X4 Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of X4 Pharmaceuticals (XFOR) be purchased?

Yes, you can buy fractional shares of X4 Pharmaceuticals with INDmoney app.

What are the documents required to start investing in X4 Pharmaceuticals stocks?

To start investing in X4 Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of X4 Pharmaceuticals Stock (XFOR)?

Today’s highest price of X4 Pharmaceuticals (XFOR) is $0.38.

Today’s lowest price of X4 Pharmaceuticals (XFOR) is $0.35.

What is today's market capitalisation of X4 Pharmaceuticals?

Today's market capitalisation of X4 Pharmaceuticals XFOR is 61.4M

What is the 52 Week High and Low Range of X4 Pharmaceuticals Stock (XFOR)?

  • 52 Week High

    $1.60

  • 52 Week Low

    $0.26

What are the historical returns of X4 Pharmaceuticals (XFOR)?

  • 1 Month Returns

    -39.04%

  • 3 Months Returns

    -45.82%

  • 1 Year Returns

    -62.03%

  • 5 Years Returns

    -95.98%

Who is the Chief Executive Officer (CEO) of X4 Pharmaceuticals ?

Dr. Paula Ragan Ph.D. is the current Chief Executive Officer (CEO) of X4 Pharmaceuticals.